Rutgers: Researchers Uncover Triple Immunotherapy Combination As Potential Treatment For Pancreatic Cancer
January 25, 2023
January 25, 2023
NEW BRUNSWICK, New Jersey, Jan. 25 (TNStalk)(TNSjou) -- Rutgers University issued the following Q&A on Jan. 24, 2023, with Prateek Gulhati, physician-scientist in the Gastrointestinal Oncology Program at Cancer Institute and assistant professor of medicine at Robert Wood Johnson Medical School:
* * *
A newly identified regimen resulted in tumor regression and improved survival, according to a Rutgers study
* * *
Pancreatic ductal adenocarci . . .
* * *
A newly identified regimen resulted in tumor regression and improved survival, according to a Rutgers study
* * *
Pancreatic ductal adenocarci . . .